Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01996345 · ClinicalTrials.gov registry record · NA
Vaginal Pessary Versus Expectant Management for Placenta Previa
A NA study, sponsored by Pediatrix.
- Terminated
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT01996345 is a NA study that was terminated before completion, run by Pediatrix. The registered enrollment target is 17 participants.
The verdict
NCT01996345, a NA study, was terminated before completion, sponsored by Pediatrix.
- TERMINATED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
The purpose of this study is to perform a large multi-center randomized trial comparing the role of vaginal pessary versus expectant management in women with placenta previa between 22w0d and 32w0d of gestation in prolonging gestation until ≥36 weeks. Secondary outcomes will assess duration of antepartum admission, total blood loss, gestational age at delivery, type of cesarean delivery, and a composite neonatal outcome. The hypothesis is that the use of a vaginal pessary in patients presenting with placenta previa between 22-32 weeks will decrease delivery prior to 36 weeks as compared to expectantly managing these patients.
Interventions
- PROCEDURE Cervical Pessary Placement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2016-10 |
| Est. Completion | 2018-09-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01996345
The ClinicalTrials.gov registry entry for NCT01996345 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pediatrix, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cervical Pessary Placement is the first listed.
NCT01996345 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01996345 about?
NCT01996345 is a clinical study titled "Vaginal Pessary Versus Expectant Management for Placenta Previa". The purpose of this study is to perform a large multi-center randomized trial comparing the role of vaginal pessary versus expectant management in women with placenta previa between 22w0d and 32w0d of gestation in prolonging gestation until ≥36 weeks. Secondary outcomes will assess duration of antep...
What is the current status of trial NCT01996345?
This trial is currently terminated. It is a NA study. The enrollment target is 17 participants. The study started on 2016-10. Estimated completion is 2018-09-05.
What interventions are being tested in trial NCT01996345?
The interventions under investigation include: Cervical Pessary Placement (PROCEDURE).
Who is sponsoring clinical trial NCT01996345?
This trial is sponsored by Pediatrix, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.